FDA Approved: AMPHOTERICIN B — Supplemental Application (XGen Pharmaceuticals DJB, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Amphotericin B submitted by XGen Pharmaceuticals DJB, Inc. This approval authorizes a change to the approved product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Blastomycosis
• Candidiasis
• Coccidioidomycosis
• Cryptococcal Meningitis
• Histoplasmosis
• Invasive Fungal Infections
• Mucormycosis

Drugs mentioned

• Amphotericin B (Amphotericin B)

Snippet

SUPPL AP for AMPHOTERICIN B (AMPHOTERICIN B)